Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year survival below 30% ...
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) has appointed Kent Taylor as senior vice president of sales to lead its ...